Ziprasidone in the treatment of mania in bipolar disorder

References

• AllisonDBMentoreJLHeoM1999Antipsychotic-induced weight gain: a comprehensive research synthesisAmerican Journal of Psychiatry15616869610553730
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association1992Tardive dyskinesia: a task force report of the American Psychiatric AssociationWashington, DC
   Google Scholar
• American Psychiatric Association2000Diagnostic and statistical manual of mental disorders4th ed, text revisionWashington, DC
   Google Scholar
• American Psychiatric Association2002Practice guideline for the treatment of patients with bipolar disorder revisionAmerican Journal of Psychiatry159Suppl150
   Google Scholar
• AnanthJBurgoyneKSNizD2004Tardive dyskinesia in 2 patients treated with ziprasidoneJournal of Psychiatry and Neuroscience29467915644988
   PubMed Web of Science ®Google Scholar
• AnanthJParameswaranSGunatilakeS2004aSide effects of atypical antipsychotic drugsCurrent Pharmaceutical Design1022192915281897
   PubMed Web of Science ®Google Scholar
• AnanthJParameswaranSGunatilakeS2004bNeuroleptic malignant syndrome and atypical antipsychotic drugsJournal of Clinical Psychiatry654647015119907
   PubMed Web of Science ®Google Scholar
• ApseloffGMulletDWilnerKD2000The effects of ziprasidone on steady-state lithium levels and renal clearance of lithiumBritish Journal of Clinical Pharmacology49Suppl 161S64S10771456
   PubMed Web of Science ®Google Scholar
• ArbuckDM200512,800-mg ziprasidone overdose without significant ECG changesGeneral Hospital Psychiatry27222315882771
   PubMed Web of Science ®Google Scholar
• BaldassanoCFBallasCDattoSM2003Ziprasidone-associated mania: a case series and review of the mechanismBipolar Disorders572512656943
   PubMed Web of Science ®Google Scholar
• BarnettMS2004Ziprasidone monotherapy in pediatric bipolar disorderJournal of Child and Adolescent, Psychopharmacology14471715650505
   PubMed Web of Science ®Google Scholar
• BerkowitzA2003Ziprasidone for dementia in elderly patients: case reviewJournal of Psychiatric Practice94697315985971
   PubMedGoogle Scholar
• BorovickaMCBondLCGaughanKM2006Ziprasidone- and lithium-induced neuroleptic malignant syndromeAnnals of Pharmacotherapy401394216352776
   PubMed Web of Science ®Google Scholar
• BowdenCL2005Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorderJournal of Clinical Psychiatry3121915762830
   PubMed Web of Science ®Google Scholar
• Bristol-Myers Squibb Company2006Abilify prescribing information
   Google Scholar
• CaroffSNMannSC1993Neuroleptic malignant syndromeMedical Clinics of North America771852028093494
   PubMed Web of Science ®Google Scholar
• CatalanoGGraceJWCatalanoMC2005Acute akathisia associated with quetiapine usePsychosomatics4629130116000672
   PubMed Web of Science ®Google Scholar
• ChengappaKNSuppesTBerkM2004Treatment of bipolar mania with atypical antipsychoticsExpert Review of Neurotherapeutics4 6 Suppl 2S172516279862
   PubMedGoogle Scholar
• ColeSASaleemRSheaWP2005Ziprasidone for agitation or psychosis in dementia: four casesInternational Journal of Psychiatry in Medicine3591815977947
   PubMed Web of Science ®Google Scholar
• DanielDGBrookeSWarringtonLE2004IM ziprasidone in agitated patients with bipolar diagnosesPresented at National Institute of Mental Health New Clinical Drug Evaluation Unit, 44th Annual MeetingPheonix, AZ
   Google Scholar
• DanielDGPotkinSGReevesKR2001Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trialPsychopharmacology1551283411401000
   PubMed Web of Science ®Google Scholar
• EndicottJCohenJNeeJ1981Hamilton Depression Rating Scale. Extracted from regular and change versions of the schedule for affective disorders and schizophreniaArchives of General Psychiatry38981037458574
   PubMed Web of Science ®Google Scholar
• EndicottJSpitzerRL1978A diagnostic interview: the schedule for affective disorders and schizophreniaArchives of General Psychiatry3583744678037
   PubMed Web of Science ®Google Scholar
• ErnstCLGoldbergJF2002The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropicsJournal of Clinical Psychiatry4425511913676
   PubMed Web of Science ®Google Scholar
• EversonGLasseterKCAndersonKE2000The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic functionBritish Journal of Clinical Pharmacology49Suppl 121S26S10771450
   PubMed Web of Science ®Google Scholar
• GentileS2007Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorderJournal of Clinical Psychopharmacology271354517224710
   PubMed Web of Science ®Google Scholar
• GentileS2006Long-term treatment with atypical antipsychotics and the risk of weight gain: a literature analysisDrug Safety2943031916569080
   PubMed Web of Science ®Google Scholar
• GhaemiSNHsuDJRosenquistKJ2006Extrapyramidal side effects with atypical neuroleptics in bipolar disorderProgress in Neuro Psychopharmacology and Biological Psychiatry302091316412546
   PubMed Web of Science ®Google Scholar
• GillHSDeVaneCLRischSC1997Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypothesesJournal of Clinical Psychopharmacology17377899315989
   PubMed Web of Science ®Google Scholar
• Gomez-CriadoMSBernardoMFlorezT2005Ziprasidone overdose: cases recorded in the database of Pfizer-Spain and literature reviewPharmacotherapy251660516232029
   PubMed Web of Science ®Google Scholar
• GrayNS2004Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson’s disease: a diagnostic challengeHuman Psychopharmacology19205715079855
   PubMed Web of Science ®Google Scholar
• GrecoKETuneLEBrownFW2005A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patientsJournal of Clinical Psychiatry66928916013910
   PubMed Web of Science ®Google Scholar
• GuyW1976Early clinical drug evaluation manualWashington, DCUnited States Department of Health, Education, and Welfare
   Google Scholar
• HarriganEPMiceliJJAnzianoR2004A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibitionJ Clin Psychopharmacol2462914709949
   PubMed Web of Science ®Google Scholar
• HeinrichTWBibloLASchneiderJ2006Torsades de pointes associated with ziprasidonePsychosomatics47264816684946
   PubMed Web of Science ®Google Scholar
• HirschSRKisslingWBaumlJ2002A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophreniaJournal of Clinical Psychiatry635162312088164
   PubMed Web of Science ®Google Scholar
• IsometsaETHenrikssonMMAroHM1994Suicide in bipolar disorder in FinlandAmerican Journal of Psychiatry151102048010358
   PubMed Web of Science ®Google Scholar
• Janssen2007Risperdal prescribing information
   Google Scholar
• KaneJMSmithJM1982Tardive dyskinesia: prevalence and risk factors, 1959 to 1979Archives of General Psychiatry39473816121548
   PubMed Web of Science ®Google Scholar
• KaySRFiszbeinAOplerLA1987The positive and negative syndrome scale (PANSS) for schizophreniaSchizophrenia Bulletin13261763616518
   PubMed Web of Science ®Google Scholar
• KeckMEMullerMBBinderEB2004Ziprasidone-related tardive dyskinesiaAmerican Journal of Psychiatry161175614702272
   PubMed Web of Science ®Google Scholar
• KeckPEJrPopeHGJrCohenBM1989Risk factors for neuroleptic malignant syndrome. A case-control studyArchives of General Psychiatry4691482572206
   PubMed Web of Science ®Google Scholar
• KeckPEJrVersianiMPotkinS2003Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trialAmerican Journal of Psychiatry160741812668364
   PubMed Web of Science ®Google Scholar
• KeckPEJrWarringtonLPotkinS2004Efficacy and safety of ziprasidone in bipolar disorder: short- and long-term data157th annual meeting of the American Psychiatric AssociationNew York, NY
   Google Scholar
• KowatchRADelBelloMP2006Pediatric bipolar disorder: emerging diagnostic and treatment approachesChild and Adolescent Psychiatric Clinics of North America157310816321726
   PubMed Web of Science ®Google Scholar
• LeiboldJPatelVHasanRA2004Neuroleptic malignant syndrome associated with ziprasidone in an adolescentClinical Therapeutics261105815336475
   PubMed Web of Science ®Google Scholar
• LiebermanJAStroupTSMcEvoyJP2005Effectiveness of antipsychotic drugs in patients with chronic schizophreniaNew England Journal of Medicine35312092316172203
   PubMed Web of Science ®Google Scholar
• LevyWORobichaux-KeeneNRNunezC2004No significant QTc interval changes with high-dose ziprasidone: a case seriesJournal of Psychiatric Practice102273215552544
   PubMedGoogle Scholar
• LipinskiJFJrMallyaGZimmermanPPopeHGJr1989Fluoxetine-induced akathisia: clinical and theoretical implicationsJournal of Clinical Psychiatry50339422549018
   PubMed Web of Science ®Google Scholar
• LesoLSchwartzTL2002Ziprasidone treatment of deliriumPsychosomatics4361211927760
   PubMed Web of Science ®Google Scholar
• MarkenPAPiesRW2006Emerging treatments for bipolar disorder: safety and adverse effect profilesAnnals of Pharmacotherapy402768516403851
   PubMed Web of Science ®Google Scholar
• MasonMNJohnsonCEPiaseckiM2005Ziprasidone-induced acute dystoniaAmerican Journal of Psychiatry162625615741487
   PubMed Web of Science ®Google Scholar
• McIntyreRSKonarskiJZ2005Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorderJournal of Clinical Psychiatry3283615762832
   PubMed Web of Science ®Google Scholar
• McKennaKKorenGTetelbaumM2005Pregnancy outcome of women using typical antipsychotic drugs: a prospective comparative studyJournal of Clinical Psychiatry66444915816786
   PubMed Web of Science ®Google Scholar
• MendhekarDN2005Ziprasidone-induced tardive dyskinesiaCanadian Journal of Psychiatry Revue Canadienne de Psychiatrie50567816262114
   PubMed Web of Science ®Google Scholar
• MiceliJJWilnerKDHansenRA2000Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteersBritish Journal of Clinical Pharmacology49Suppl 15S13S10771448
   PubMed Web of Science ®Google Scholar
• MichalopoulouPGLykourasL2006Manic/hypomanic symptoms induced by atypical antipsychotics: a review of the reported casesProgress in Neuro Psychopharmacology and Biological Psychiatry305496416442194
   PubMed Web of Science ®Google Scholar
• MiodownikCHausmannMFrolovaK2005Lithium intoxication associated with intramuscular ziprasidone in schizoaffective patientsClinical Neuropharmacology28295716340388
   PubMed Web of Science ®Google Scholar
• MontgomerySAAsbergM1979A new depression scale designed to be sensitive to changeBritish Journal of Psychiatry1343829444788
   PubMed Web of Science ®Google Scholar
• MukherjeeSRosenAMCaracciG1986Persistent tardive dyskinesia in bipolar patientsArchives of General Psychiatry4334262869742
   PubMed Web of Science ®Google Scholar
• MurtyRGMistrySGChackoRC2002Neuroleptic Malignant Syndrome with ziprasidoneJournal of Clinical Psychopharmacology22624612454565
   PubMed Web of Science ®Google Scholar
• NasrallahHAChurchillCMHamdan-AllanGA1988Higher frequency of neuroleptic-induced dystonia in mania than in schizophreniaAmerican Journal of Psychiatry145145562903686
   PubMed Web of Science ®Google Scholar
• NemeroffCBLiebermanJAWeidenPJ2005From clinical research to clinical practice: a 4-year review of ziprasidoneCNS Spectrums10s120
   PubMed Web of Science ®Google Scholar
• NewcomerJW2005Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature reviewCNS Drugs19Supp 119315998156
   PubMed Web of Science ®Google Scholar
• OzenMEYumruMSavasHA2007Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatmentWorld Journal of Biological Psychiatry842417366349
   PubMed Web of Science ®Google Scholar
• PapakostasGIPetersenTJNierenbergAA2004Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorderJournal of Clinical Psychiatry652172115003076
   PubMed Web of Science ®Google Scholar
• PatelNCKeckPEJr2006Ziprasidone: efficacy and safety in patients with bipolar disorderExpert Review of Neurotherapeutics611293816893341
   PubMedGoogle Scholar
• PerlisRHWelgeJAVornikLA2006Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trialsJournal of Clinical Psychiatry675091616669715
   PubMed Web of Science ®Google Scholar
• Pfizer2007Geodon prescribing information
   Google Scholar
• PierreJM2005Extrapyramidal symptoms with atypical antipsychotics: incidence, prevention and managementDrug Safety2819120815733025
   PubMed Web of Science ®Google Scholar
• PotkinSGKeckPEJrSegalS2005Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trialJournal of Clinical Psychopharmacology253011016012271
   PubMed Web of Science ®Google Scholar
• PotkinSGKeckPEGillerE2004Ziprasidone in bipolar mania: efficacy across patient subgroupsPresented at the 157th annual meeting of the American Psychiatric AssociationNew York, NY
   Google Scholar
• PrevalHKlotzSGSouthardR2005Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic studyGeneral Hospital Psychiatry27140415763126
   PubMed Web of Science ®Google Scholar
• PrietoTBenabarreABernardoM2005The highest intentional ziprasidone overdose was not fatalActa Psychiatrica Scandinavica112798015952953
   PubMed Web of Science ®Google Scholar
• RamosAEShytleRDSilverAA2003Ziprasidone-induced oculogyric crisisJournal of the American Academy of Child and Adolescent Psychiatry421013412964566
   PubMed Web of Science ®Google Scholar
• RosenquistKJWalkerSSGhaemiSN2002Tardive dyskinesia and ziprasidoneAmerican Journal of Psychiatry159143612153846
   PubMed Web of Science ®Google Scholar
• SchmidtAWLebelLAHowardHRJr2001Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profileEuropean Journal of Pharmacology42519720111513838
   PubMed Web of Science ®Google Scholar
• SimpsonSGJamisonKR1999The risk of suicide in patients with bipolar disordersJournal of Clinical Psychiatry253610073388
   PubMed Web of Science ®Google Scholar
• SpragueDALoewenPSRaymondCB2004Selection of atypical antipsychotics for the management of schizophreniaAnnals of Pharmacotherapy382313914742771
   PubMed Web of Science ®Google Scholar
• SuppesTDennehyEB2001Bipolar disorder algorithmsTIMA procedural manualDallas2001
   Google Scholar
• SuppesTDennehyEBHirschfeldRM2005The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorderJournal of Clinical Psychiatry668708616013903
   PubMed Web of Science ®Google Scholar
• SwiftRHHarriganEPCappelleriJC2002Validation of the behavioral activity rating scale (BARS): a novel measure of activity in agitated patientsJournal of Psychiatric Research36879511777497
   PubMed Web of Science ®Google Scholar
• VietaE2005Bipolar mixed states and their treatmentExpert Review of Neurotherapeutics563815853475
   PubMedGoogle Scholar
• VornikLAHirschfeldRM2005Bipolar disorder: quality of life and the impact of atypical antipsychoticsAmerican Journal of Managed Care119 SupplS2758016232010
   PubMed Web of Science ®Google Scholar
• WeidenPJDanielDGSimpsonG2003Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidoneJournal of Clinical Psychopharmacology2359560014624190
   PubMed Web of Science ®Google Scholar
• WeinsteinSKAdlerCMStrakowskiSM2006Ziprasidone-induced acute dystonic reactions in patients with bipolar disorderJournal of Clinical Psychiatry67327816566635
   PubMed Web of Science ®Google Scholar
• WeislerRDunnJEnglishP2003Ziprasidone in adjunctive treatment of acute bipolar mania: randomized, double-blind, placebo-controlled trial55th Institute on Psychiatric Services MeetingBoston, MA
   Google Scholar
• WeislerRWarringtonLDunnJ2004Adjunctive ziprasidone in bipolar mania: short- and long-term data157th annual meeting of the American Psychiatric AssociationNew York, NY
   Google Scholar
• WirshingWC2001Movement disorders associated with neuroleptic treatmentJournal of Clinical Psychiatry2115811584982
   PubMed Web of Science ®Google Scholar
• YangSHMcNeelyMJ2002Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidoneAmerican Journal of Psychiatry159143512153844
   PubMed Web of Science ®Google Scholar
• YoungCCLujanE2004Intravenous ziprasidone for treatment of delirium in the intensive care unitAnesthesiology1013794515329607
   PubMed Web of Science ®Google Scholar
• YoungRCBiggsJTZieglerVE1978A rating scale for mania: reliability, validity and sensitivityBritish Journal of Psychiatry13342935728692
   PubMed Web of Science ®Google Scholar